I Sonic Medical France

i Sonic Medical Makers of Next Generation non Contact Tonometers for glaucoma monitoring Industry sectors Medtech Therapeutics Area Ophthalmology
Your innovative solution

Vibration tonometry enables smart tonometers to measure eye pressure without contact,for ophthalmologists, refractive surgeons , otpicians and optometrists and self monitoring at home.

Which problem are you solving ?

Vibration tonometers measure eye pressure independently of corneal thickness and even in people with thin corneas or after refractive surgery

Target market segments

1 Ophthalmologists/ 2 Refractive Surgeons/ 3 opticians & Optometrists/ 4 people with glaucoma or at risk

Key value proposition

1 Fast Repeated measures/ 2 Works on Thin Cornea/3 Measures Corneal elasticity/4 Works after refrtactive surgery


i2a France

i2a Founded over 25 years ago, i2a develops microbiology instruments, software, reagents and consumables. i2a is now launching a Total Bacteriology Lab Automation solution. Industry sectors Medtech Therapeutics Area Immunology
Infectious Diseases - Vaccines
Ivd / Diagnostics
Your innovative solution

i2a is a company working on microbiology automation. The objective is to offer a global solution from the arrival of samples to the final results. i2a manufactures and sells pre-analytical device, automatic incubator automatic reader-incubator, software, reagents and consumables. The current total bacteriology automation proposed by i2a strengthens quality, optimizes sample flow, enhances flexibility and reduces costs.

Which problem are you solving ?

Each clinical microbiology laboratory is unique and its organization may vary, but they all have seen a 10 

Target market segments

Market segment 1: Hospital Clinical Lab of Microbiology Market segment 2: Reference Lab of Microbiology Market segment 3: Small and Medium Private Lab of Microbiology

Key value proposition

Advantage 1: Strenghten quality Advantage 2: Enhance flexibility Advantage 3: Optimize sample flow Advantage 4: Reduce costs

Christian Curel
CEO & Founder 

Icahn School of Medicine at Mount Sinai United States

The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, which includes seven hospital campuses, and has more than 5,000 faculty and nearly 2,000 students, residents and fellows. Our unwavering pursuit of intellectual exchange, breakthrough research, and multidisciplinary teamwork propels us ever forward in biomedical discoveries and advances. We pursue ideas that often challenge conventional wisdom to revolutionize the practice of medicine and produce dramatically better outcomes for patients. We make big, bold bets by investing in radical free thinkers and technology at the cutting edge.

Dr Maria New
Pediatric Endocrinologist 

Icahn School of Medicine at Mount Sinai United States

Professor John He
Chief of Nephrology 

Icahn School of Medicine at Mount Sinai United States

Dr Rhoda Sperling
Professor - ObGyn and Medical ID 

Icahn School of Medicine at Mount Sinai, (MSSM) United States

At the Icahn School of Medicine at Mount Sinai, we are dramatically advancing the art and science of medical care through an atmosphere of intense collaborative learning, social concern, and scholarly inquiry.

We pursue innovative approaches to education, research and patient care, combining the best traditions of medicine with the principles and entrepreneurial thinking of a startup, to uncover novel insights about disease. Building this culture of innovation requires making large investments and taking a transformative approach to discovery, which means taking risks and disrupting the status quo. In this way, we are transforming the practice of medicine and reinventing medical research to produce radically better outcomes for patients.

We seek a variety of students who can contribute open-mindedness, empathy, social insight, medical, scientific, technological and engineering expertise, to change the very nature of medicine. We have developed a number of admissions and training programs to foster these advances and recruit multi-talented students from richly diverse backgrounds, in a non-traditional way.

We continually pioneer innovative approaches in our medical and graduate education curricula that instill entrepreneurism, encourage critical thinking and equip the next generation of basic and clinical scientists with cutting-edge methodological and technological skills to translate scientific discovery into practice and improve public health.

We have ambitious goals, preparing scientists, physicians, and leaders who will make significant contributions to local and global health care, remaining forever inquisitive in their quest for lifelong growth, learning, and contribution. We train in the classroom and the laboratory, at the bedside, and in the community. Our unwavering commitment to intellectual exchange, multidisciplinary teamwork, and innovation continually drives us forward in discoveries, advances, and service.

As a leader in biomedical research, we have hired accomplished scientists and executives with startup experience and melded them with Mount Sinai’s doctors and researchers, spurring new levels of collaboration among our faculty. We are an engine of discovery, creating new treatments for the patients who need them the most, working in partnership with leading high-tech companies.  We are on the threshold of a new era in precision medicine, and our mission is to cure diseases once thought incurable, changing the lives of patients worldwide.

James Manfredi

Icahn School of Medicine at Mt. Sinai United States

Professor Ronald Gordon
Professor of Pathology & Director of Core Electron Microscopy Facility 

ICDNavigator United States

Our mission has ALWAYS been clear, i.e. assist with healthcare ICD-10 coding in two ways, high tech yet high touch!

--> High Tech – hosted online ICDNavigator using Big Data technology

Most stand-alone or embedded EMR ICD-10 solutions JUST FALL short. Majority are either using CMS GEM (General Equivalent Mapping) or relational data-base driven application or algorithms.

CMS by it own admission states a disclaimer that their ICD-9 to ICD-10 general equivalency mapping is rudimentary and UNDER NO CURCUMSTANCE SHOULD BE RELIED UPON SOLELY with ICD-10 coding. The facts are few ICD-9 map one on one to ICD-10 and the explosion from 13,000 ICD-9 CM to 68,000 ICD-10CM codes makes it apparent that GEMS is at a best a LIMITED guide toward the transitions from ICD-9CM to ICD-10CM.

EMR vendors on the other hand rely on antiquated old-school, pre-BIG DATA information technologies like SQL relational databases that serve well defined data well as most corporations have in the past.

Post Internet era however, unstructured DATA seems to be dominating databases what with blogs, social media, XML and user driven data that would be impossible to contain in traditional SQL relational database tables. Imagine the folly of Google using relational data bases instead of it page-ranking, search driven algorithms to catalog the billions of Internet web pages.

ICDNavigator recognized the absurdity of such an approach with ICD-10 & therefore designed and developed using BIG DATA driven NoSQL, search indexing technologies like SOLR, Apache Lucene, etc. 

ICDNavigator has managed to do what most big EMR vendors or stand-alone physician practice management software CAN NOT DO, i.e develop a sophisticated interactive tool that allow ALL data related to a ICD-10 codes produced from a diagnoses keyword search that works like Google. That aside, the same interactive user screen driven application can be ‘packaged and embedded’ as RESTFUL API programming interfaces into virtually any site or within any application.

Another HUGE advantage to the unstructured DATA approach ICDNavigator has taken is that the hosted application is customizable via simple KEYWORD addition by the use at the site WITHOUT ANY PROGRAMMING. Doing so allows us to LET USERS at the site create simulated Superbills, for example, by merely associating KEYWORDS entered by physician or staff thus creating site or physician specific ICD-10 codes matched to CPT codes used to bill the provider services with. 

--> High Touch – acknowledging fully well that no software solution ONLY will do the job 

ICDNavigator is truly one of a kind in this respect. Aside from offering a FREE version of ICDNavigator or an OPTIONAL monthly fee based PREMIUM ICDNavigator version, we back up our solution with our ICDNavigator Call Center staffed ICD-10 medical coders to assist either thru a phone call or Live Chat/Screen-Share Feature.

Imagine getting stuck with a specific code and not knowing where to for FAST and ACCURATE on the spot HELP with choosing the very specific ICD-10 code you need based on diagnoses or being informed additional High Risk codes you can bill may be included if applicable from case to case.

Only ICDNavigator offers on-demand, LIVE HELP WHEN YOU NEED IT from our remote ICD-10 coders who cn walk you through how ICDNavigator works for specific search or even general ICD-10 problems specific to your need ICDNavigator notwithstanding.

Mr Ram Balani

ICV, Inc. United States

ICV hosts events which bring together the CEOs of private and public growth companies and family offices and fund investors in a collaborative and safe environment. In one year, our events grew sixfold in attendance, without advertising; we grew because of the quality of the people. 

Our experience as investors attending conferences and group formats in the financial industry has shown us that most company outreach events have the same feel. Overcrowded with those that inhibit the networking process and rapid fire presentations by CEOs who then race off with little to no substantive interaction after the fact, these experiences seem to leave investor attendees with unanswered questions about the top person in command, the investment opportunity, or why it can’t be done better. We believe it can. 

ICV’s response to these engagement gaps at most investor events have been to create a novel medium for both companies AND investors. Whilst presentations remain at the core of the agenda, the pace is much more relaxed and designed to allow investor attendees to get to know management and fellow investors without the distraction of service provider booths and sponsorship talks. The focus shifts exclusively to listening to company presentations while building rapport and relationships through group Q&A and due diligence sessions following each CEO presentation. Companies are carefully curated for quality, with most sourced by investor attendees or based on their investment criteria, to ensure that the attendees are seeing the kind and quality of company they seek. 

No more ten minute speed dating with ICV, we give investors two days in an intimate environment to ask all their questions and to see company management in many different settings. When it comes to investing, ICV believes that with a more complete picture of a company and especially its leaders, investors can feel more confident that their returns will be more secure.


Events, Retreats, Roadshows, Research

Mr Luke Dean

IM Strategic Partners United States

Ideas Matter. Throughout all of human existence, great ideas have caused tectonic shifts in the way we think, live, work, play, and heal. But having a great idea isn’t enough. Great ideas must be nurtured, developed, and driven with singular focus and relentless passion.

IM Strategic Partners (“IMSP”) was founded on the principle that strategic thinking must be coupled with strategic execution to achieve success… and a little luck along the way is nice, too.

Recognizing the changing landscape of healthcare, and health and wellness generally, IMSP was founded by Chance Gibson in 2008 on the principle that the challenges we face are too big for any one organization, or even an entire industry sector, to solve alone. Effectively addressing the issue of the health of America requires the collaboration of traditionally non-traditional partners. Insurance companies must partner with fitness companies, food companies must partner with tech companies, beverage companies must partner with healthcare professional societies, and everyone must learn to work within an ever-changing regulatory environment.

Mr Chance Gibson